Miércoles, 2 de septiembre de 2009

Accede a los webcasts de la sesión de cierre del Congreso Europeo de Cardiología que se ha desarrollado en Barcelona en 2009. Prestigiosos expertos procedentes de más de 140 países se dieron cita en Barcelona durante cuatro días para abordar el futuro de la especialidad a medio plazo.

Presentación	Ponente	Tema
Results of a strategy integrating transfemoral and transapical aortic valve implantation in high-risk patients with aortic stenosis.	D Himbert (Paris, FR)	Valvular disease
Transcatheter aortic valve implantation in patients with low Euroscore but presenting with anatomical or technical contraindications to conventional surgery.	M Taramasso (Milan, IT)	Valvular disease
Initial experiences with a non-stented coronary sinus device for the treatment of functional mitral regurgitation: results of the PTOLEMY I feasibility trial.	S Sack (Munich, DE)	Valvular disease
Percutaneous treatment of the mitral regurgitation with the MitraClip System in patients with severely reduced left ventricular function - first european experience.	O W Franzen (Hamburg, DE)	Valvular disease
State of the Art - Percutaneous valve intervention. Where is it going?	B Iung (Paris Cedex 18, FR)	Valvular disease
Impact of bleeding types on mortality after PCI: Results from a patient-level pooled analysis of the REPLACE-2, ACUITY and HORIZONS trials.	R Mehran (New York, US)	Interventional cardiology
REPLACE-2, ACUITY, HORIZONS: Discussant.	W Wijns (Aalst, BE)	Interventional cardiology
Survival in patients with heart failure and preserved versus impaired left ventricular ejection fraction: an individual patient data meta-analysis: MAGGIC.	R Doughty (Auckland, NZ)	Heart failure / LV dysfunction
RE-LY: Discussant.	J-P Collet (Paris, FR)	Arrhythmias / Pacing / Resynchronisation
Clinical outcome after thrombectomy or standard angioplasty in patients with ST elevation myocardial infarction: individual patient-data pooled analysis of 11 randomized trials. ATTEMPT.	F Burzotta (Roma, IT)	Ischaemia / ACS / infarction
ATTEMPT: Discussant.	E Eeckhout (Lausanne, CH)	Ischaemia / ACS / infarction
Optimal revascularization strategy in patients with three-vessel disease and/or left main disease: The 2 year outcomes of the SYNTAX Trial.	AP Kappetein (Rotterdam, NL)	Ischaemia / ACS / infarction
SYNTAX: Discussant.	M J Antunes (Coimbra, PT)	Ischaemia / ACS / infarction
Fractional Flow Reserve versus Angiography for Guiding PCI - 2 year outcome.	N H J Pijls (Eindhoven, NL)	Interventional cardiology
FFR vs Angriography for Guiding PCI: Discussant.	T F Luescher (Zurich, CH)	Interventional cardiology
Basic science: Highlight Session	B Casadei (Oxford, GB)	Cardiovascular system (patho)physiology
Hypertension and risk factors: Highlight Session	R Fagard (Leuven, BE)	Hypertension
Imaging: Highlight Session	F E Rademakers (Leuven, BE)	Myocardial-Pericardial disease
Arrhythmias: Highlight Session	P E Vardas (Heraklion, GR)	Arrhythmias / Pacing / Resynchronisation
Acute coronary syndromes: Highlight Session	K A A Fox (Edinburgh, GB)	Ischaemia / ACS / infarction
Interventional cardiology: Highlight Session	C Di Mario (London, GB)	Interventional cardiology
Valvular heart disease: Highlight Session	R Rosenhek (Wien, AT)	Valvular disease
Heart failure and cardiomyopathies: Highlight Session	M Metra (Brescia, IT)	Heart failure / LV dysfunction
Prevention: Highlight Session	J Perk (Oskarshamn, SE)	Epidemiology & prevention
MAGGIC: Discussant.	DM Kaye (Melbourne, AU)	Heart failure / LV dysfunction

Cardiología hoy | Blog

Guías clínicas

Agenda SEC

CardioPODCAST

Cursos SEC

Másteres y Posgrados

Formación SEC 2025

CardioTV

Miércoles, 2 de septiembre de 2009

Actualidad

Revista Española de Cardiología

REC: Interventional Cardiology

REC: CardioClinics

Socios estratégicos